Page 1 Page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Page 8 Page 9 Page 10 Page 11 Page 12 Page 13 Page 14 Page 15 Page 16 Page 17 Page 18 Page 19 Page 20 Page 21 Page 22 Page 23 Page 24 Page 25 Page 26 Page 27 Page 28 Page 29 Page 30 Page 31 Page 3215 JAPAN – Intensive AdvaMed advocacy helped ensure changes to Japan’s reimbursement rules were at the positive end of what was anticipated, and prevented adoption of a proposed “market expansion repricing rule” that would have led to deep reimburse- ment cuts for products with higher sales than projected. Japan also continued to make progress under an AdvaMed-supported regulatory performance plan aimed at improving patient access to innovation. INDIA – AdvaMed continued to seek adoption of pending legislation that would carve out an appropriate, globally harmo- nized regulatory framework for medical devices, as distinct from drugs. AdvaMed also redoubled its efforts to address mounting political pressure for price controls in the country, forming a PR task force, enlisting the assistance of a new consulting firm, and initiating a study to examine barriers to patient access in India. The Association aims to work with India’s government and other stakeholders to increase awareness of the value of medical tech- nology and improve patient access to needed care. EUROPEAN UNION – As the EU continues to move toward significant revisions to its regulatory system for devices and diagnostics, AdvaMed worked in close collaboration with MedTech Europe (an alliance of European medtech industry associations) to address key issues and press for maintaining the safety and efficiency of the EU’s current, decentralized regulatory approach. These efforts included organizing meetings between AdvaMed members and officials in EU member states to help make our case. AdvaMed International Board Committee Chairman Kevin Lobo, chairman and CEO of Stryker (at right), and William Jin, managing director of Stryker Greater China and vice chair of AdvaMed’s China executive committee and board (at left) participate in an AdvaMed member CEO delegation to Beijing in May. AdvaMed Chairman Vince Forlenza, chairman, president and CEO of BD, meets with Japan Prime Minister Shinzo Abe in April to discuss the Trans-Pacific Partnership agreement.